The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing - Heier, J S; Boyer, D; Nguyen, Q DCLEAR-IT 2 Investigators (Ophthalmology, 2011)
et al.